Status:
UNKNOWN
Combined On-demand Sildenafil Citrate and Tramadol Hydrochloride for Treatment of Premature Ejaculation
Lead Sponsor:
Assiut University
Conditions:
Premature Ejaculation
Eligibility:
MALE
18-50 years
Phase:
PHASE4
Brief Summary
Premature Ejaculation (PE) is a common sexual dysfunction that has a negative impact on both sex partners. Several lines of treatment have been proposed for the treatment of PE i.e. psychological, beh...
Detailed Description
It's clear that PE poses much burden not only on the patient sexual life but also on all aspects of the life of both the patient and his partner. Several treatment options have been proposed for treat...
Eligibility Criteria
Inclusion
- no previous medical treatment for PE
- history of premature ejaculation (PE), primary or secondary, and a maximum IELT of 2 minutes prior to treatment.
Exclusion
- drug noncompliance, positive history of diabetes mellitus, psychological problems, neurological disorders, erectile dysfunction, chronic illnesses, interpersonal troubles with the spouse, as well as long term medications that could affect the patient condition.
Key Trial Info
Start Date :
December 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 25 2022
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT05183334
Start Date
December 30 2021
End Date
December 25 2022
Last Update
January 10 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.